HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 447-453

  Dunn, F W ^a,c   Roux, M H ^a   Farhadian, F ^b   Sabri, K ^b   Ossart, C ^a   Samuel, J L ^b   Rappaport, L ^b   Hamon, G ^a  

^a SANOFI   (France)

^b Inst Natl de la S et de la R M   (France)

^c Roussel Uclaf   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; 2 BUTYL 4 METHYLTHIO 1 [[2' [[[(PROPYLAMINO)CARBONYL]AMINO]SULFONYL][1,1' BIPHENYL] 4 YL]METHYL] 1H IMIDAZOLE 5 CARBOXYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; FIBRONECTIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL ISOLATION; CELL VOLUME; CONCENTRATION RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT; RECEPTOR AFFINITY; SMOOTH MUSCLE FIBER; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BIPHENYL COMPOUNDS; CELLS, CULTURED; FIBRONECTINS; IMIDAZOLES; LEUCINE; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; TETRAZOLES;

EID: 0030933943     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. BERK, B. C., VEKSHTEIN, V., GORDON, H. M. AND TSUDA, T.: Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13: 305-314, 1989.
2. BEVAN, R. D.: An autoradiographic and pathologic study of cellular proliferation in rabbits correlated with an increase in arterial pressure. Blood Vessels 13: 100-28, 1976.
3. BRIAND, V., RIVA, L. AND GALZIN, A. M.: Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells. Br. J. Pharmacol. 112: 1195-1201, 1994.
4. BUMPUS, F. M., CATT, K. J., CHIU, A. T., DEGASPARO, M., GOODFRIEND, T., HUSAIN, A., PEACH, M. J., TAYLOR, D. G. AND TIMMERMANS, B. M. W. M.: Nomenclature for angiotensin receptors. A report of the nomenclature committee of the council for high blood pressure research. Hypertension 17: 720-721, 1991.
5. BUNKENBURG, B., VAN AMELSVOORT, T., ROGG, H. AND WOOD, J.: Receptor mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 20: 746-757, 1992.
6. CAMPBELL, G. R., CAMPBELL, J. H., MANDERSON, J. A., HORRIGAN, S. AND RENNICK, R. E.: Arterial smooth muscle cell: a multifunctional mesenchymal cell. Arch. Pathol. Lab. Med. 122: 977-986, 1988.
7. CHAMLEY-CAMPBELL, J. H., CAMPBELL, G. R. AND ROSS, R.: The smooth muscle cell in culture. Physiol. Rev. 59: 1-55, 1979.
8. CHIU, A. T., HERBLIN, W. F., MCCALL, D. E., ARDECKY, R. J., CARINI, D. J., DUNCIA, J. V., PEASE L. J., WONG, P. C., WEXLER, R. R., JOHNSON, A. L. AND TIMMERMANNS B. M. W. M.: Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 165: 196-203, 1989.
9. CHIU, A. T., ROSCOE, W. A., MCCALL. D. E. AND TIMMERMANS, B. M. W. M.: Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor 1: 133-140, 1991.
10. CHOMCZYNSKI, P. AND SACCHI, N.: Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 156-159, 1987.
11. CRAWFORD, D. C., CHOBANIAN, A. V. AND BRECHER, P.: Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ. Res. 74: 727-739, 1994.
12. DEPREZ, P., GUILLAUME, J., BECKER, R., CORBIER, A., DIDIERLAURENT, S., FORTIN, M., FRECHET, D., HAMON, G., HECKMANNN B., HEITSCH, H., KLEEMANN, H-W., VEVERT, J-P., VINCENT, J-C., WAGNER, A. AND ZHANG, J.: Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenyl) sulfonylurea (HR720). J. Med. Chem. 38: 2357-21377, 1995.
13. FARHADIAN, F., BARRIEUX, A., LORTET, S., MAROTTE, F., OLIVIERO, P., RAPPAPORT, AND SAMUEL, J. L.: Differential splicing of fibronectin pre-messenger ribonucleic acid during cardiac ontogeny and development of hypertrophy in the rat. Lab Invest. 71: 552-559, 1994.
14. FARHADIAN, F., CONTARD, F., CORBIER, A., BARRIEUX, A., A., RAPPAPORT, L. AND SAMUEL, J. L.: Fibronectin expression during physiological and pathological cardoac growth. J. Mol. Cell. Cardiol. 27: 981-990, 1995.
15. FFRENCH-CONSTANT, C.: Alternative splicing of fibronectin - Many different Proteins but few different functions. Exp. Cell Res. 221: 261-271, 1995.
16. FISMAN, J. A., RYAN, G. B. AND KARNOVSKY, M. J.: Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab. Invest. 32: 339-351, 1975.
17. GEISTERFER, A. A. T., PEC, M. J. AND OWENS, G. K.: Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756, 1988.
18. HAHN, A. W. A., JONAS, U., BUEHLER, F. R. AND RESINK, T. J.: Identification of a fourth angiotensin AT1 receptor subtype in rat. Biochem. Biophys. Res. Commun. 192: 1260-1265, 1993a.
19. HAHN, A. W. A., REGENASS, S., KERN, F., BÜHLER, F. R. AND RESINK, T. J.: Expression of soluble and insoluble fibronectin in rat aorta: Effects of angiotensin II and endothelin-1. Biochem. Biophys. Res. Commun. 192: 189-197, 1993b.
20. HALL, M. M., KHOSLA, M. C., KHAIRALLAH, P. A. AND BUMPUS, F. M.: Angiotensin analogs: The influence of sarcosine substitution in position 1. J. Pharmacol. Exp. Ther. 188: 222-228, 1974.
21. HOLLANDER, W.: Role of hypertension in atherosclerosis and cardiovascular disease. Am. J. Cardiol. 38: 786-800, 1976.
22. HOSOI, M., TAKASAKI, I., PAVLOV-REZAKOVA, A., HIMENO, H., CHOBANIAN, A. V. AND BRECHER, P.: Selective induction of an embryonic fibronectin isoform in the rat aorta in vitro. Circ. Res. 73: 689-695, 1993.
23. KATO, H., SUZUKI, H., TAJIMA, S., OGATA, Y., TOMINAGA, T., SATO, A. AND SARUTA, T.: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J. Hypertension 9: 17-22, 1991.
24. KIM, S., OHTA, K., HAMAGUCHI, A., OMURA, T., TOMINAGA, K., YUKIMURA T., MIURA, K., TANAKA, M., IWAO, H.: AT-1 receptor-mediated stimulation by angiotensin II of rat aortic fibronectin expression in vivo. Br. J. Pharmacol. 113: 662-663, 1994.
25. KOH, E., MORIMOTO, S., TOMITA, J., RAKUGI, H., JIANG, B., INOUE, T., NABATA, T., FUKUO, K. AND OGIHARA, T.: Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 23: 175-179, 1994.
26. KORNBLIHTT, A. R., PESCE, C. G., ALONSO, C. R., CRAMER, P., SHEBROW, A., WERBAJH, S. AND MURO, A. F.: The fibronectin gene as a model for splicing and transcription studies. FASEB J. 10: 248-257, 1996.
27. MAMUYA, W. S. AND BRECHER, P.: Fibronectin expression in the normal and hypertrophic rat heart. J. Clin. Invest. 89: 392-401, 1992.
28. MAMYA, W., CHOBANIAN, A. AND BRECHER, P.: Age-related changes in fibronectin expression in spontaneously hypertensive Wistar-Kyoto, and Wistar rat hearts. Circ. Res. 71: 1341-1350, 1992.
29. MCBRIDE, W., LANGE, R. A. AND HILLS, L. D.: Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N. Engl. J. Med. 318: 1734-1737, 1988.
30. MCPHERSON, G. A.: Analysis of radiolabeled binding experiments: A collection of computer programs for the IBM PC. J. Pharmacol. Methods 14: 213-228, 1985.
31. MILLET, D., DESGRANGES, D., CAMPAN, M., GADEAU, A-P. AND COUSTEROUSSE, O.: Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells. Eur. J. Biochem. 206: 367-372, 1992.
32. OWENS, G. K., RABINOVITCH, P. S., SCHWARTZ, S. M.: Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc. Natl. Acad. Sci. U.S.A. 78: 7759-7763, 1981.
33. OWENS, G. K.: Differential effects of antihypertensive therapy on vascular smooth muscle cell hypertrophy, hyperploidy and hyperplasia in the spontaneously hypertensive rat. Circ. Res. 56: 525-536, 1985.
34. OWENS, G. K. AND REIDY, M.: Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ. Res. 57: 695-705, 1985.
35. OWENS, G. K.: Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 9: 178-187, 1987.
36. OWENS, G. K.: Control of hypertrophic versus hyperplasic growth of vascular smooth muscle cells. Am. J. Physiol. 257: H1755-H1765, 1989.
37. REBUFFAT, P., BELLONI, A. S., MAZZOCCHI, G., VASSANELLI, P. AND NUSSDORFER, G. G.: A stereological study of the trophic effects of the renin-angiotensin system on rat adrenal zona glomerulosa. J. Anat. 60: 760-772, 1979.
38. ROSS, R. AND GLOMSET, I. A.: Atherosclerosis and the arterial smooth muscle cell. Science 180: 1332-1339, 1973.
39. SACHINIDIS, A., KO, Y., WEISSER, P., MEYER ZU BRICKWEDDE, M-K., DÜSING, R., CHRISTIAN, R., WIECZOREK, A. J. AND VETTER, H.: EXP3174, a metabolite of losartan (MK954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells. J. Hypertension 11: 155-162, 1993.
40. SAMUEL, J. L., BARRIEUX, A., DUFOUR, S., DUBUS, I., CONTARD, F., KOTELIANSKY, V., FARHADIAN, F., MAROTTE, F., THIÉRY, J-P. AND RAPPAPORT, L.: Accumulation of fetal fibronectin mRNAs during the development of cardiac hypertrophy induced by pressure overload. J. Clin. Invest. 88: 1737-1746, 1991.
41. SAMUEL, J. L., FARHADIAN, F., SABRI, A., MAROTTE, F., ROBERT, V. AND RAPPAPORT, L.: Expression of fibronectin during rat fetal and post-natal development: An in situ hybridization and immunohistochemical study. Cardiovasc. Res. 28: 1653-1661, 1994.
42. SAOUAF, R., TAKASAKI, I., EASTMAN, E., CHOBANIAN, A. V. AND BRECHER, P.: Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. J. Clin. Invest. 88: 1182-1189, 1991.
43. SCHWARZBAUER, J. E., PATEL, R. S., FONDA, D. AND HYNES, R. O.: Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J. 6: 2573-2580, 1987.
44. SCOTT-BURDEN, T., RESINK, T. J., BAUR, U., BÜRGIN, M. AND BÜHLER, F. R.: Amilorid sensitive activation of S6-kinase by angiotensin II in cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 151: 583-589, 1988.
45. SCOTT-BURDEN, T., RESINK, T. J., BÜRGIN, M., BÜHLER, F. R.: Extracellular matrix: Differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats. J. Cell. Physiol. 141: 267-274, 1989.
46. SCOTT-BURDEN, T., HAHN, A. W. A., RESINK AND BÜHLER, F. R.: Modulation of extracellular matrix by angiotensin II: Stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 16: S36-S41, 1990.
47. SCOTT-BURDEN, T., HAHN, A. W. A., BÜHLER, F. R. AND RESINK, T. J.: Vasoactive peptides and growth factors in the pathophysiology of hypertension. J. Vasc. Pharmacol. 20: S55-S64, 1992.
48. SREETEN, D. H. P., ANDERSON, G. H., FREIBERG, J. M., DALAKOS, T. G.: Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension. N. Engl. J. Med. 292: 657-662, 1975.
49. STADLER, E., CAMPBELL, J. H. AND CAMPBELL, G. R.: Do cultured smooth muscle cells resemble those of the artery wall? If not, why not? J. Cardiovasc. Pharmacol. 14: S1-S8, 1989.
50. SUNG, C-P., ARLETH, A. J., STORER, B. L. AND OHLSTEIN, E. H.: Angiotensin type 1 receptor mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 271: 429-437, 1994.
51. TAKASAKI, I., CHOBANIAN, A., SARZANI, R. AND BRECHER, P.: Effect of hypertension on fibronectin expression in the rat aorta. J. Biol. Chem. 265: 21935-21939, 1990.
52. TAKASAKI, I., CHOBANIAN, A. V. AND BRECHER, P.: Biosynthesis of fibronectin by rabbit aorta. J. Biol. Chem. 26: 17686-17694, 1991.
53. TAKASAKI, I., CHOBANIAN, A., SARZANI, R. AND BRECHER, P.: Hypertension induces, alternatively spliced forms of fibronectin in rat aorta. Hypertension 20: 20-25, 1992.
54. VISWANATHAN, M., TSUTSUMI, K., CORREA, F. M. A. AND SAAVEDRA, J. M.: Changes in expression of angiotensin receptor subtypes in rat aorta during development. Biochem. Biophys. Res. Commun. 179: 1361-1367, 1991.
55. WHITEBREAD, S., MELE, M., KAMBER, B. AND DE GASPARO, M.: Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163: 284-291, 1989.
56. WISSLER, R. W.: The arterial medial cell, smooth muscle of multifunction-mesenchyme? J. Atherosclerosis Res. 8: 201-213, 1968.
57. WOLINSKY, H. AND DALY, M. M.: A method for the isolation of intima-media samples from arteries. Proc. Soc. Exp. Biol. Med. 135: 364-368, 1970.
58. WONG, P. C., HART, S. D., ZASPEL, A. M., CHIU, A. W., ARDECK, R. J., SMITH, R. D. AND TIMMERMANS, B. M. W. M.: Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD 123177 (AII-2). J. Pharmacol. Exp. Ther. 255: 584-592, 1990.